Form 4: Cardlytics CEO Sells Shares Amidst Stock Split

Cardlytics CEO Amit Gupta reported transactions involving the sale of company stock following a 1-for-10 reverse stock split.

Summary

• Amit Gupta, CEO of Cardlytics, Inc. (CDLX), reported transactions on July 1st and July 6th, 2026.
• On July 1st, 2026, Gupta acquired 12,500 shares and 18,750 restricted stock units (RSUs).
• Following these acquisitions, Gupta beneficially owned 111,238 shares directly and 129,988 shares directly.
• On July 2nd, 2026, Gupta sold 6,498 shares at a weighted average price of $4.395.
• On July 6th, 2026, Gupta sold 9,640 shares at a weighted average price of $4.394.
• These transactions occurred after Cardlytics effected a 1-for-10 reverse stock split on June 5th, 2026, with reported numbers adjusted accordingly.
• RSU vesting schedules are detailed: 50% vested April 1, 2026, with the remainder vesting quarterly through April 1, 2027; another RSU award vests quarterly through April 1, 2028.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing with a slightly negative sentiment due to the CEO's stock sales, although the context of RSUs and a reverse stock split mitigates a more severe negative interpretation.

Positives

• The CEO's RSUs continue to vest, indicating ongoing employment and commitment.
• The reverse stock split may be an attempt to improve the stock's market perception and meet exchange listing requirements.

Negatives

• The CEO sold a significant number of shares shortly after acquiring RSUs and following a reverse stock split.
• The weighted average sale prices for the disposed shares were $4.395 and $4.394.

Risks

• The sale of shares by the CEO could be interpreted as a lack of confidence in the company's short-term prospects.
• The effectiveness of a reverse stock split in improving long-term shareholder value is not guaranteed.

Future Outlook

The filing does not contain explicit forward-looking statements or guidance. However, the vesting schedules for RSUs indicate continued employment and potential future share issuances.

Management Comments

• The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).
• The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4).

Industry Context

StockSavvy.ai notes that insider selling, especially by C-suite executives, can be a signal to the market. However, in the context of a recent reverse stock split, these sales might be part of a pre-planned strategy or to cover tax liabilities associated with vesting RSUs, rather than a direct reflection of negative company outlook.

Stakeholder Impact

• Shareholders may view the CEO's stock sales with caution, potentially impacting short-term stock price sentiment.
• Employees with RSUs will see their awards vest according to the established schedules, subject to continued employment.

Next Steps

• Continued vesting of restricted stock units as per the outlined schedules.
• Potential for further disclosures if the CEO or other insiders engage in additional transactions.

Key Dates

Recommendation

The filing details insider transactions, specifically sales by the CEO, which can be a negative signal. However, these sales occurred after a reverse stock split and are tied to RSU vesting, suggesting they may not solely reflect a lack of confidence. Without broader financial performance data or strategic updates, a 'hold' recommendation is prudent, advising investors to await further information before making significant decisions.

Keywords

Form 4, Insider Trading, Cardlytics, CDLX, Amit Gupta, CEO, Stock Sale, Restricted Stock Units, Reverse Stock Split, Beneficial Ownership